Nicox S.A. (ALCOX.PA)

EUR 0.23

(-1.74%)

Total Liabilities Summary of Nicox S.A.

  • Nicox S.A.'s latest annual total liabilities in 2023 was 31.56 Million EUR , down -5.91% from previous year.
  • Nicox S.A.'s latest quarterly total liabilities in 2023 FY was 31.56 Million EUR , down -5.91% from previous quarter.
  • Nicox S.A. reported annual total liabilities of 33.55 Million EUR in 2022, down -14.1% from previous year.
  • Nicox S.A. reported annual total liabilities of 39.05 Million EUR in 2021, down -5.73% from previous year.
  • Nicox S.A. reported quarterly total liabilities of 31.56 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Nicox S.A. reported quarterly total liabilities of 36.75 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Nicox S.A. (2023 - 2019)

Historical Annual Total Liabilities of Nicox S.A. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 31.56 Million EUR -5.91%
2022 33.55 Million EUR -14.1%
2021 39.05 Million EUR -5.73%
2020 41.43 Million EUR 168.25%
2019 15.44 Million EUR 0.0%

Peer Total Liabilities Comparison of Nicox S.A.

Name Total Liabilities Total Liabilities Difference
European Medical Solutions 33.86 Million EUR 6.789%
FERMENTALG 19.39 Million EUR -62.733%
argenx SE 402.79 Million EUR 92.163%
BioSenic S.A. 32.26 Million EUR 2.16%
Celyad Oncology SA 9.97 Million EUR -216.366%
Hyloris Pharmaceuticals SA 8.61 Million EUR -266.547%
Onward Medical N.V. 25.69 Million EUR -22.838%
Oxurion NV 19.73 Million EUR -59.946%
PHAXIAM Therapeutics S.A. 25.69 Million EUR -22.853%
Financière de Tubize SA 123.65 Million EUR 74.471%
UCB SA 6.56 Billion EUR 99.519%